Department of Pediatrics, University of Chicago, Chicago, Illinois, USA.
Department of Surgery, University of Chicago, Chicago, Illinois, USA.
J Med Ethics. 2018 Dec;44(12):843-850. doi: 10.1136/medethics-2018-104762. Epub 2018 Jul 4.
Both living donor transplantation and human subjects research expose one set of individuals to clinical risks for the clinical benefits of others. In the the National Commission for the Protection of Human Subjects of Biomedical and Behavior Research (National Commission) articulated three principles to serve as the basis for a research ethics framework: respect for persons, beneficence and justice. In contrast, living donor transplantation lacks a framework. In this manuscript, we adapt the three principles articulated in the to serve as the foundation for an ethics framework for living donor transplantation which we supplement with the principles of vulnerability and responsibility. The National Commission supported additional protections for vulnerable groups of potential research participants. In 2001, Kenneth Kipnis effectively argued that the concept of vulnerable groups failed to explore in what ways particular groups of people were vulnerable, thereby risking unnecessary protections for some and inadequate protections for others. He proposed a taxonomy that explored different types of vulnerabilities that all research participants may experience to provide a more robust framework for human subjects protections, which we adapt to living donors. Robert Goodin claims that health professionals, who stand in special relationship with patients, are responsible for promoting and protecting their well-being. In living donor transplantation, the donor transplant team is responsible for empowering prospective donors to address their vulnerabilities and/or for protecting those who cannot by disqualifying them from donation.
活体供者移植和人体受试者研究都使一组人面临临床风险,以惠及他人。在国家生物医学和行为研究人类受试者保护委员会(国家委员会)阐述了三项原则,作为研究伦理框架的基础:尊重个人、善行和公正。相比之下,活体供者移植缺乏框架。在本文中,我们将国家委员会阐述的三项原则改编为活体供者移植的伦理框架基础,并补充了脆弱性和责任原则。国家委员会支持为潜在研究参与者的弱势群体提供额外保护。2001 年,Kenneth Kipnis 有效地指出,弱势群体的概念未能探讨特定群体在哪些方面是脆弱的,从而有可能对一些人不必要地保护,而对另一些人保护不足。他提出了一种分类法,探讨了所有研究参与者可能经历的不同类型的脆弱性,为人体受试者保护提供了更强大的框架,我们将其改编为活体供者。Robert Goodin 声称,与患者有特殊关系的医疗保健专业人员有责任促进和保护他们的福祉。在活体供者移植中,供者移植团队有责任赋予潜在供者权力,以解决他们的脆弱性问题,或者通过取消他们的供者资格来保护那些无法解决脆弱性问题的供者。